Hemp and CBD Federal Roundup: March 2020
By David Gately and David Kramer
Mar 23, 2020
A summary of recent hemp and CBD news and developments in light of coronavirus and federal updates from the FDA and USDA.
Insights
Coronavirus and Cannabis: Physical Distancing Guide for Cannabis Businesses
By Alex Lamphier
Mar 20, 2020
Steps that cannabis operators can take to encourage physical distancing in an effort to reduce the potential coronavirus (COVID-19) spread throughout the cannabis community.
FDA Issues Long-Awaited CBD Update in Report to Congress and Public Statement
By Shawn Hauser, Partner
Mar 12, 2020
The FDA issued its first report to Congress, along with a public update regarding its progress in evaluating lawful pathways for the marketing of CBD products and considering a risk-based enforcement policy. Read the summary from VS Hemp Department leader, Shawn Hauser.
Protecting Your CBD Business from Product Liability Lawsuits
By Michelle Bodian
Mar 9, 2020
With any new consumer product craze, lawsuits will inevitably follow. The hemp-CBD industry is no exception. The current wave of CBD-related lawsuits has primarily been product liability claims.
California and the Gig Economy: The Fight Over AB-5
By David Kramer, Senior Associate
Mar 3, 2020
California employers beware: as of January 1, 2020, it is increasingly likely that any person who performs services for your company will be classified as an employee. The reason for this seismic shift is Assembly Bill 5 (AB-5).
WELCOME TO VICENTE INSIGHTS!
Commentary and analysis on cannabis, hemp, psychedelics, and other emerging therapies from the attorneys and policy specialists at the nation’s leading cannabis law firm.